http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9410981-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44981a6abeaacab6218cf75cd292f4f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09e11ed1a17f4e3103b67d44e1cd68b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ac7f6d3bde4cd9b683e1fcd9b2e518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f998d20f078d724b1a8bebaaa0716b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5d77f943e61d04d5c215cabae5d0261
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
filingDate 1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a93ce40e4dacb8c707e5671dd2c2c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd841edffb3472e9a128bb225bd1c4cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fa7eed218cab8ebb0f6cbe0e873040
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba796e38bbd2e7fd892de3df5da6908b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1dee11afb3360a5bbdc8d087f3a1b11
publicationDate 1994-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9410981-A1
titleOfInvention Prolonged-action pharmaceutical preparation
abstract A prolonged-action pharmaceutical preparation comprising a macrocyclic compound represented by 17-alkyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04.9]octa-cos-18-ene-2,3,10,16-tetrone or 17-ethyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04.9]octa-cos-18-ene-2,3,10,16-tetrone enclosed in a so-called microsphere, i.e., a fine particle of a biodegradable macromolecular substance. When this preparation is administered in the form of a parenteral solution, the macrocyclic compound can very well migrate in the blood. Further it is suited for topical administration.
priorityDate 1992-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61148181-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66672804
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID198914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226715784
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID198914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66672926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226716293

Total number of triples: 35.